India scraps requirements of J&J to conduct COVID-19 vaccine trials in India

While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement

Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India as per reports from "The Economic Times"

While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement, according to the report.